×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
Contracts and Agreements: How can the QPPV achieve oversight ?
Session Chair(s)
Margaret Anne Walters
Deputy EU Qualified Person for Pharmacovigilance
Merck, Sharp & Dohme Ltd, United Kingdom
Speaker(s)
License Partner Oversight, Towards a Comprehensive Approach
Philip J. Weatherill
Ipsen Biopharm Ltd., United Kingdom
Director, Global Pharmacovigilance
Challenges with Updating Agreements through Product Lifecycles and With Changing Expectations
Gro Laier, MD
Denmark
PV Expert
Auditing for Compliance and/or Sharing PSMF and Inspection Data – The future?
Pam Bones, PhD
Allergan, Inc., United Kingdom
Head, Global Regulatory Quality-PV
Have an account?